These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9816014)

  • 41. Survivin expression is associated with features of biologically aggressive prostate carcinoma.
    Shariat SF; Lotan Y; Saboorian H; Khoddami SM; Roehrborn CG; Slawin KM; Ashfaq R
    Cancer; 2004 Feb; 100(4):751-7. PubMed ID: 14770431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling.
    Wells A; Souto JC; Solava J; Kassis J; Bailey KJ; Turner T
    Clin Cancer Res; 2002 Apr; 8(4):1251-7. PubMed ID: 11948140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells.
    Angelucci A; Festuccia C; Gravina GL; Muzi P; Bonghi L; Vicentini C; Bologna M
    Prostate; 2004 May; 59(2):157-66. PubMed ID: 15042616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells.
    Dorai T; Dutcher JP; Dempster DW; Wiernik PH
    Prostate; 2004 Jun; 60(1):1-17. PubMed ID: 15129424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).
    Ling MT; Wang X; Lee DT; Tam PC; Tsao SW; Wong YC
    Carcinogenesis; 2004 Apr; 25(4):517-25. PubMed ID: 14688027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
    Volante M; Saviozzi S; Rapa I; Ceppi P; Cappia S; Calogero R; Novello S; Borasio P; Papotti M; Scagliotti GV
    Cancer; 2007 Sep; 110(6):1321-8. PubMed ID: 17647268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness.
    Yamanaka Y; Friess H; Kobrin MS; Buchler M; Beger HG; Korc M
    Anticancer Res; 1993; 13(3):565-9. PubMed ID: 8317885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate.
    Adams JY; Leav I; Lau KM; Ho SM; Pflueger SM
    Prostate; 2002 Jun; 52(1):69-81. PubMed ID: 11992621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of transforming growth factor-alpha and epidermal growth factor receptor mRNA in the gastric mucosa of portal hypertensive rats.
    Hsieh JS; Wang JY; Lin SR; Hsieh TJ; Huang TJ
    Hepatogastroenterology; 2003; 50(53):1305-10. PubMed ID: 14571724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.
    Song JI; Lango MN; Hwang JD; Drenning SD; Zeng Q; Lamph WW; Grandis JR
    Cancer Res; 2001 Aug; 61(15):5919-25. PubMed ID: 11479234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas.
    Christensen ME; Therkildsen MH; Poulsen SS; Bretlau P
    J Pathol; 1993 Mar; 169(3):323-8. PubMed ID: 8492225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis.
    Fujiwara Y; Higuchi K; Hamaguchi M; Takashima T; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Arakawa T
    J Gastroenterol Hepatol; 2004 May; 19(5):521-7. PubMed ID: 15086595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of epithelial growth factor receptor and its two ligands, transforming growth factor-alpha and epithelial growth factor, in normal and neoplastic squamous cells in the vulva: an immunohistochemical study.
    Wu X; Xin Y; Yao J; Hasui K; Tsuyama S; Yonezawa S; Murata F
    Med Electron Microsc; 2001 Sep; 34(3):179-84. PubMed ID: 11793194
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The expression of transforming growth factor-alpha and epidermal growth factor receptor in human fetal ovary].
    Liu X; Zheng Y
    Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):82-4. PubMed ID: 11809104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical localization of transforming growth factor-alpha and transforming growth factor-beta during early human fetal prostate development.
    Raghow S; Shapiro E; Steiner MS
    J Urol; 1999 Aug; 162(2):509-13. PubMed ID: 10411079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
    Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
    Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.
    Jia RP; Xu LW; Su Q; Zhao JH; Li WC; Wang F; Xu Z
    Asian J Androl; 2008 Sep; 10(5):758-64. PubMed ID: 18645679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.